or Try an Advanced Search...

    Adoptive Cell Transfer Stocks List

    Symbol Grade Name % Change
    ALLO D Allogene Therapeutics, Inc. -8.09
    CERO D CERo Therapeutics Holdings, Inc. 36.53
    IOVA D Iovance Biotherapeutics, Inc. -9.01
    CLLS F Cellectis S.A. 3.40
    ADAP F Adaptimmune Therapeutics plc -3.69
    IMTX F Immatics N.V. -6.19
    ACET F Adicet Bio, Inc. -4.76
    View As Page of Charts
    Related Industries: Biotechnology Other
    Related Stock Lists: Cancer Medicine Biopharmaceutical Cancer Immunotherapy Cell Therapy Clinical Medicine Immune System Immunotherapy Solid Tumors Biotechnology Cancer Treatment Tumors Of The Hematopoietic And Lymphoid Tissues Virotherapy Breast And Lung Cancer Cancer Immunotherapy Product Chimeric Antigen Receptor Hematological Malignancies Immunotherapy Products Melanoma Multiple Myeloma

    Related ETFs - A few ETFs which own one or more of the above listed Adoptive Cell Transfer stocks.

    Symbol Grade Name Weight
    CNCR C Loncar Cancer Immunotherapy ETF 5.03
    WDNA F WisdomTree BioRevolution Fund 3.11
    IDNA C iShares Genomics Immunology and Healthcare ETF 2.87
    BBP B BioShares Biotechnology Products Fund 1.93
    LABD F Direxion Daily S&P Biotech Bear 3X Shares 1.61
    View all Adoptive Cell Transfer ETFs...
    Compare ETFs
    Compare CNCR to LABD Compare IDNA to BBP Compare WDNA to BBP

        Adoptive Cell Transfer Stocks Recent News

        Date Stock Title
        Nov 12 ADAP Adaptimmune Q3 2024 Earnings Preview
        Nov 11 CERO Crude Oil Down 3%; Aramark Posts Upbeat Earnings
        Nov 11 CERO CERo Therapeutics Stock Is Soaring Monday: What's Going On?
        Nov 11 IOVA Iovance Biotherapeutics Q3: A Beat, But A Selloff - Now A Buy Opportunity
        Nov 11 CERO CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
        Nov 9 IOVA Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
        Nov 8 IMTX Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME
        Nov 8 ALLO Allogene's Q3 Loss Narrower Than Expected, Sales Nil
        Nov 8 IOVA IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top line
        Nov 8 IOVA Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ...
        Nov 8 ALLO Allogene Therapeutics Inc (ALLO) Q3 2024 Earnings Call Highlights: Financial Resilience Amidst ...
        Nov 8 ALLO Allogene Therapeutics, Inc. (ALLO) Q3 2024 Earnings Call Transcript
        Nov 8 IOVA Iovance Biotherapeutics, Inc. (IOVA) Q3 2024 Earnings Call Transcript
        Nov 7 IOVA Iovance falls 12% despite Q3 beats; reaffirms 2024 revenue guidance
        Nov 7 IOVA Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates
        Nov 7 IOVA Iovance Biotherapeutics: Q3 Earnings Snapshot
        Nov 7 ALLO Allogene Therapeutics GAAP EPS of -$0.32 beats by $0.01
        Nov 7 ALLO Allogene Therapeutics: Q3 Earnings Snapshot
        Nov 7 IOVA Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M
        Nov 7 ALLO Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
        Related Industries: Biotechnology Other
        Related Stock Lists: Cancer Medicine Biopharmaceutical Cancer Immunotherapy Cell Therapy Clinical Medicine Immune System Immunotherapy Solid Tumors Biotechnology Cancer Treatment Tumors Of The Hematopoietic And Lymphoid Tissues Virotherapy Breast And Lung Cancer Cancer Immunotherapy Product Chimeric Antigen Receptor Hematological Malignancies Immunotherapy Products Melanoma Multiple Myeloma
        Adoptive Cell Transfer

        Adoptive cell transfer (ACT) is a type of immunotherapy that involves taking immune cells from a patient, modifying them in the laboratory, and then infusing them back into the patient to help fight cancer. ACT works by boosting the patient’s own immune system to recognize and attack cancer cells. It is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia.

        Browse All Tags